News
Hosted on MSN2mon
Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses ExpectationsHealthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results , with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million ...
Hosted on MSN1mon
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?2025 Roadmap Looks Impressive: In terms of its financial roadmap, Omnicell is targeting to reach $1.9-$2 billion in revenues by 2025, representing a CAGR of 14-15% in the 2021-2025 period ...
Omnicell (NASDAQ:OMCL) has had a rough three months with its share price down 21%. We, however decided to study the company's financials to determine if they have got anything to do with the price ...
Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...
Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, ...
Omnicell (NASDAQ:OMCL) has had a rough three months with its share price down 21%. We, however decided to study the company's financials to determine if they have got anything to do with the price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback